← Back to Search

Cognitive Behavioral Therapy vs. Sudarshan Kriya Yoga for Depression in IBD

N/A
Recruiting
Led By Jill Gaidos, MD, FACG
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Verified Crohn's disease
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, week 6, week 12, week 24 and week 52
Awards & highlights

Study Summary

This trial will compare the effects of CBT versus SKY on anxiety and depression in people with IBD.

Who is the study for?
This trial is for individuals with Crohn's disease who are stable on anxiety or depression meds, without dose changes in the last 12 weeks. They should not have active intestinal inflammation and must commit to the full study duration. Non-English speakers, those with severe mental illness, or active inflammation are excluded.Check my eligibility
What is being tested?
The study aims to see if Cognitive Behavioral Therapy (CBT) or Sudarshan Kriya Yoga (SKY) can improve anxiety and depression in people with Inflammatory Bowel Disease (IBD). Participants will be randomly assigned to either CBT or SKY treatment groups.See study design
What are the potential side effects?
While CBT typically does not cause physical side effects, it may bring up uncomfortable emotions. SKY might lead to mild discomfort like headache or fatigue during initial practice but generally has minimal risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Crohn's disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 6, week 12, week 24 and week 52
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 6, week 12, week 24 and week 52 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in anxiety scores using the Generalized Anxiety Disorder-7 (GAD-7) questionnaire
Mental Depression

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Sudarshan Kriya YogaExperimental Treatment1 Intervention
Participants in this arm will participate in SKY to assess the impact it will have on anxiety or depression among patients with Crohn's disease
Group II: Cognitive Behavioral TherapyActive Control1 Intervention
Participants in this arm will participate in CBT to assess the impact it will have on anxiety or depression among patients with Crohn's disease
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sudarshan Kriya Yoga
2019
Completed Phase 2
~330

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,852 Previous Clinical Trials
2,738,289 Total Patients Enrolled
Crohn's & Colitis Foundation of America (CCFA)UNKNOWN
Jill Gaidos, MD, FACGPrincipal InvestigatorYale University

Media Library

Cognitive Behavioral Therapy Clinical Trial Eligibility Overview. Trial Name: NCT05377840 — N/A
Crohn's Disease Research Study Groups: Cognitive Behavioral Therapy, Sudarshan Kriya Yoga
Crohn's Disease Clinical Trial 2023: Cognitive Behavioral Therapy Highlights & Side Effects. Trial Name: NCT05377840 — N/A
Cognitive Behavioral Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05377840 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical experiment currently have any openings for volunteers?

"Affirmative. The clinicaltrials.gov portal verifies that this medical trial, which was initiated on July 5th 2022, is presently recruiting participants. 152 individuals need to be sourced from 1 different medical centre."

Answered by AI

What is the present size of the patient cohort in this investigation?

"Affirmative. According to the information posted on clinicaltrials.gov, this medical trial is currently enrolling patients. The study was first published on July 5th 2022 and its details were recently updated on July 11th 2022; 152 participants are needed at one location."

Answered by AI
~38 spots leftby Dec 2024